Früherkennung der Alzheimer-Krankheit mit Biomarkern der Bildgebung oder aus dem Liquor

Translated title of the contribution: Early detection of Alzheimer's Disease using imaging or cerebro-spinal fluid biomarkers

Research output: Contribution to journalArticlepeer-review

Abstract

Just recently, new diagnostic criteria for Alzheimer's disease (AD) allow the diagnosis of the disease solely on biomarkers independently from the clinical syndrome. In particular, biomarkers for Amyloid pathology already become abnormal many years before symptom onset. In addition, if biomarkers for Tau and neurodegeneration turn positive, diagnostic specificity and probability deterioration increases substantially. The usefulness of the AD biomarkers for early detection and prognosis will be discussed. AD biomarkers allow the detection of AD already at the pre-dementia level. This offers the opportunity to identify candidates for disease-modifying treatment options.

Translated title of the contributionEarly detection of Alzheimer's Disease using imaging or cerebro-spinal fluid biomarkers
Original languageGerman
Pages (from-to)813-816
Number of pages4
JournalNervenheilkunde
Volume38
Issue number11
DOIs
StatePublished - 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Early detection of Alzheimer's Disease using imaging or cerebro-spinal fluid biomarkers'. Together they form a unique fingerprint.

Cite this